RepTB: a gene ontology based drug repurposing approach for tuberculosis
Abstract Tuberculosis (TB) is the world’s leading infectious killer with 1.8 million deaths in 2015 as reported by WHO. It is therefore imperative that alternate routes of identification of novel anti-TB compounds are explored given the time and costs involved in new drug discovery process. Towards...
Main Authors: | Anurag Passi, Neeraj Kumar Rajput, David J. Wild, Anshu Bhardwaj |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Cheminformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13321-018-0276-9 |
Similar Items
-
Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01) -
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
by: Parul Singhal, et al.
Published: (2016-01-01) -
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01) -
Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory
by: Azger Dusthackeer, et al.
Published: (2015-01-01) -
Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
by: Lia D’Ambrosio, et al.
Published: (2015-03-01)